Abstract Investigating metabolic rewiring in cancer can lead to the discovery of new treatment strategies for breast subtypes that currently lack targeted therapies. In this study, we used MMTV-Myc–driven tumors model heterogeneity, investigating differences between two histologic subtypes, epithelial–mesenchymal transition (EMT) and papillary subtypes. A combination genomic metabolomic techniq...